LPL Financial
INAB icon

LPL Financial’s IN8bio INAB Stock Holding History

LPL Financial’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-378
Closed -$1.88K – 5627
2025
Q1 		$1.88K Hold
378
– – ﹤0.01% 5339
2024
Q4 		$2.92K Sell
378
-34
-8% -$299 ﹤0.01% 5271
2024
Q3 		$3.33K Buy
+412
New +$7.46K ﹤0.01% 5151

Other funds holding INAB

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial's INAB Position: Q2 2025 in Review

LPL Financial sold out of IN8bio (INAB) in Q2 2025, closing a stake of 378 shares — an estimated $1.88K sold.

LPL Financial first reported a position in INAB in Q3 2024 and held it in 3 quarters. The position peaked at $3.33K in Q3 2024. 12 funds tracked by Wall St. Rank hold INAB as of Q2 2025.

  • LPL Financial reported no remaining IN8bio position as of Q2 2025 after selling out during the quarter.
  • LPL Financial sold 378 IN8bio shares in Q2 2025, an estimated $1.88K.
  • LPL Financial first reported a position in IN8bio in Q3 2024 and held it in 3 quarters.
  • LPL Financial's IN8bio position peaked at $3.33K in Q3 2024.
  • 12 funds tracked by Wall St. Rank held IN8bio as of Q2 2025.

Based on LPL Financial's 13F filing for Q2 2025, filed 12 Aug 2025.